Sponsor Dossier
Haleon
Sponsor Dossier for Haleon. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADVIL
- Brand: ADVILDUO
- Brand: Aquaear
- Brand: AURALGAN
- Brand: Caltrate
- Brand: Centrum
- Brand: COMBIMOL
- Brand: DE-GAS
- Device (sponsor): Dentifrice
- Device (sponsor): Dentifrice
- Device (sponsor): Denture cleanser
- Device (sponsor): Dentifrice
- Device (sponsor): Dentifrice
- Device (sponsor): Nasal irrigation saline solution, non-sterile
About
Haleon is an Australian Private Company with ABN 68 603 310 292, registered in Victoria. The company adopted the trading name Haleon from 22 June 2022, having previously operated under the business name GlaxoSmithKline Consumer Healthcare. Haleon is currently active on the Australian Business Register.
Portfolio
Haleon has 23 brands on the ARTG, of which 6 are indexable and 4 carry a Product Information document. 2 brands are PBS-listed, 1 has a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ADVIL, ADVILDUO, Aquaear, AURALGAN, Caltrate, Centrum, COMBIMOL, DE-GAS, DONNATAB, ENO, FLIXONASE, HYDROZOLE.
Therapeutic focus
— Pain Management: 9 brands — Gastroenterology: 4 brands — Complementary Medicine: 3 brands — Respiratory: 3 brands — Infectious Disease: 2 brands — Musculoskeletal: 1 brand — Dermatology: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2019-03-01, across 1 brand with a PBAC outcome on record.